Biotech Innovation, Kidney Disease Treatment, and Clinical Research by Ardelyx

  • Dan Blystone
  • 10.06.2026
Ardelyx stock edges lower to 5.54 as clinical trials portal promoted, Ardelyx reports
Ardelyx launched a clinical trials website aimed at helping patients and caregivers explore ongoing studies.The platform provides information about eligibility and the nature of participation in ...
  • Sholanke Dele
  • 02.06.2026
Ardelyx stock drops 1.48% as company focuses on IBS-C care and treatment gaps
Ardelyx is focused on advancing care for people living with IBS-C, according to a recent statement from the company.The company places an emphasis on improving patient outcomes and addressing ...
  • Dmytro Kharkov
  • 23.02.2026
Ardelyx: Collective momentum drives company achievements
Ardelyx emphasizes the power of momentum created through teamwork and shared drive. This reflects their accomplishments and the pride they take in being part of the team. Meg Frazier shares her ...